If you are looking for the GlaxoSmithKline Commitment to Access (CTA) program, you're in the right place. Novartis Pharmaceuticals Corporation recently purchased certain oncology and specialty medicines from GlaxoSmithKline, and their patient assistance program has transitioned to Novartis.

For information regarding Novartis Patient Assistance Programs or Co-Pay Assistance and Reimbursement Support Programs, please call 1-800-282-7630 or click one of the buttons below:

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2015 Novartis Pharmaceuticals Corporation. All rights reserved.

8/15 PAN-1121149